HighVista Strategies’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,100
Closed -$1.19M 160
2025
Q2
$1.19M Buy
+3,100
New +$1.12M 0.44% 95
2023
Q4
Sell
-2,911
Closed -$716K 133
2023
Q3
$716K Buy
2,911
+500
+21% +$137K 0.33% 75
2023
Q2
$732K Buy
+2,411
New +$670K 0.33% 79
2023
Q1
Sell
-890
Closed -$214K 122
2022
Q4
$214K Buy
+890
New +$199K 0.13% 100
2019
Q3
Sell
-3,900
Closed -$527K 137
2019
Q2
$527K Sell
3,900
-1,000
-20% -$126K 0.27% 60
2019
Q1
$639K Buy
4,900
+3,000
+158% +$403K 0.52% 49
2018
Q4
$236K Buy
+1,900
New +$255K 0.2% 88
2016
Q2
Sell
-45,000
Closed -$3.51M 182
2016
Q1
$3.51M Buy
+45,000
New +$3.14M 0.66% 34
2014
Q2
Sell
-102,912
Closed -$5.27M 160
2014
Q1
$5.27M Buy
102,912
+86,193
+516% +$4.29M 0.7% 32
2013
Q4
$798K Buy
+16,719
New +$773K 0.14% 93

Other funds holding HCA

HighVista Strategies's HCA Position: Q3 2025 in Review

HighVista Strategies sold out of HCA Healthcare (HCA) in Q3 2025, closing a stake of 3,100 shares — an estimated $1.19M sold.

HighVista Strategies first reported a position in HCA in Q4 2013 and held it in 10 quarters. The position peaked at $5.27M in Q1 2014. 1,286 funds tracked by Wall St. Rank hold HCA as of Q3 2025.

  • HighVista Strategies reported no remaining HCA Healthcare position as of Q3 2025 after selling out during the quarter.
  • HighVista Strategies sold 3,100 HCA Healthcare shares in Q3 2025, an estimated $1.19M.
  • HighVista Strategies first reported a position in HCA Healthcare in Q4 2013 and held it in 10 quarters.
  • HighVista Strategies's HCA Healthcare position peaked at $5.27M in Q1 2014.
  • 1,286 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2025.

Based on HighVista Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.